| Dr Steven Jasonowicz, DPM | |
|
27401 W Highway 22 Ste 125, Barrington, IL 60010-5934 | |
| (847) 381-0388 | |
| (847) 381-0811 |
| Full Name | Dr Steven Jasonowicz |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 10 Years |
| Location | 27401 W Highway 22 Ste 125, Barrington, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689092793 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 016005684 (Illinois) | Secondary |
| 213E00000X | Podiatrist | 016005684 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Good Shepherd Hospital | Barrington, IL | Hospital |
| Northwestern Medicine Mchenry Hospital | Mchenry, IL | Hospital |
| Advocate Sherman Hospital | Elgin, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Illinois Bone And Joint Institute Llc | 6002814878 | 519 |
News Archive
Results of a study by investigators at St. Jude Children's Research Hospital provide strong evidence for why the drug imatinib (Gleevec), which has revolutionized the treatment of chronic myelogenous leukemia (CML), is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
To help its physician members and their office administrators make informed decisions when implementing or upgrading an Electronic Health Record system, this month the Cooperative of American Physicians, Inc. began offering complimentary EHR support services exclusively to its more than 11,000 members.
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
In a paper just published by researchers at Chapman University, findings showed associations between psychological well-being and physical activity in adults ages 50 and older.
Photodynamic therapy (PDT) uses a combination of ultraviolet or visible light and a light-sensitive chemical, or photosensitizer, to kill cancer cells using reactive oxygen.
› Verified 8 days ago
| Provider Name | Illinois Bone And Joint Institute Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205922432 PECOS PAC ID: 6002814878 Enrollment ID: O20061110000331 |
News Archive
Results of a study by investigators at St. Jude Children's Research Hospital provide strong evidence for why the drug imatinib (Gleevec), which has revolutionized the treatment of chronic myelogenous leukemia (CML), is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
To help its physician members and their office administrators make informed decisions when implementing or upgrading an Electronic Health Record system, this month the Cooperative of American Physicians, Inc. began offering complimentary EHR support services exclusively to its more than 11,000 members.
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
In a paper just published by researchers at Chapman University, findings showed associations between psychological well-being and physical activity in adults ages 50 and older.
Photodynamic therapy (PDT) uses a combination of ultraviolet or visible light and a light-sensitive chemical, or photosensitizer, to kill cancer cells using reactive oxygen.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Jasonowicz, DPM 900 Rand Road, Suite 300, Des Plaines, IL 60016 Ph: (847) 324-3976 | Dr Steven Jasonowicz, DPM 27401 W Highway 22 Ste 125, Barrington, IL 60010-5934 Ph: (847) 381-0388 |
News Archive
Results of a study by investigators at St. Jude Children's Research Hospital provide strong evidence for why the drug imatinib (Gleevec), which has revolutionized the treatment of chronic myelogenous leukemia (CML), is often unable to prevent relapse of a particularly aggressive form of acute lymphoblastic leukemia (ALL).
To help its physician members and their office administrators make informed decisions when implementing or upgrading an Electronic Health Record system, this month the Cooperative of American Physicians, Inc. began offering complimentary EHR support services exclusively to its more than 11,000 members.
For those concerned with the troublesome effects of genetic resistance to drugs and pesticides, the conventional wisdom of evolution offers a reassuring word: In the absence of the original chemical threat, most resistance mutations would cause a disadvantage to their hosts and might be expected to quickly leave the genetic landscape once the use of a drug or insecticide is suspended or withdrawn.
In a paper just published by researchers at Chapman University, findings showed associations between psychological well-being and physical activity in adults ages 50 and older.
Photodynamic therapy (PDT) uses a combination of ultraviolet or visible light and a light-sensitive chemical, or photosensitizer, to kill cancer cells using reactive oxygen.
› Verified 8 days ago
James Baird Dpm Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 1410 S Barrington Rd, Barrington, IL 60010 Phone: 847-381-5011 | |
James Baird, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1410 S. Barrington Road, Suite 1, Barrington, IL 60010 Phone: 847-381-5011 Fax: 847-381-5052 |